Literature DB >> 9133440

FGF-stimulated outgrowth and proliferation of limb mesoderm is dependent on syndecan-3.

C N Dealy1, M R Seghatoleslami, D Ferrari, R A Kosher.   

Abstract

The outgrowth of the mesoderm of the developing limb bud in response to the apical ectodermal ridge (AER) is mediated at least in part by members of the FGF family. Recent studies have indicated that FGFs need to interact with heparan sulfate proteoglycans in order to bind to and activate their specific cell surface receptors. Syndecan-3 is an integral membrane heparan sulfate proteoglycan that is highly expressed by the distal mesodermal cells of the chick limb bud that are undergoing proliferation and outgrowth in response to the AER. Here we report that maintenance of high-level syndecan-3 expression by the subridge mesoderm of the chick limb bud is directly or indirectly dependent on the AER, since its expression is severely impaired in the distal mesoderm of the limb buds of limbless and wingless mutant embryos which lack functional AERs capable of directing the outgrowth of limb mesoderm. We have also found that exogenous FGF-2 maintains a domain of high-level syndecan-3 expression in the outgrowing mesodermal cells of explants of the posterior mesoderm of normal limb buds cultured in the absence of the AER and in the outgrowing subapical mesoderm of explants of limbless mutant limb buds which lack a functional AER. These results suggest that the domain of high-level syndecan-3 expression in the subridge mesoderm of normal limb buds is maintained by FGFs produced by the AER. Finally, we report that polyclonal antibodies against a syndecan-3 fusion protein inhibit the ability of FGF-2 to promote the proliferation and outgrowth of the posterior subridge mesoderm of limb buds cultured in the absence of the AER. These results suggest that syndecan-3 plays an essential role in limb outgrowth by mediating the interaction of FGFs produced by the AER with the underlying mesoderm of the limb bud.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9133440     DOI: 10.1006/dbio.1997.8525

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  8 in total

1.  N-syndecan deficiency impairs neural migration in brain.

Authors:  Anni Hienola; Sarka Tumova; Evgeny Kulesskiy; Heikki Rauvala
Journal:  J Cell Biol       Date:  2006-08-14       Impact factor: 10.539

Review 2.  Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators.

Authors:  Kathryn D Rodgers; James D San Antonio; Olena Jacenko
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

3.  Defining minimum essential factors to derive highly pure human endothelial cells from iPS/ES cells in an animal substance-free system.

Authors:  Yu-Ting Wu; Kuen-Jer Tsai; Chien-Yu Shih; Shiaw-Min Hwang; Ih-Jen Su; Po-Min Chiang
Journal:  Sci Rep       Date:  2015-04-13       Impact factor: 4.379

4.  Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells.

Authors:  Mari Tinholt; Benedicte Stavik; William Louch; Cathrine Rein Carlson; Marit Sletten; Wolfram Ruf; Grethe Skretting; Per Morten Sandset; Nina Iversen
Journal:  PLoS One       Date:  2015-01-24       Impact factor: 3.240

5.  Self-sustained planar intercalations due to mechanosignaling feedbacks lead to robust axis extension during morphogenesis.

Authors:  Samira Anbari; Javier Buceta
Journal:  Sci Rep       Date:  2020-07-03       Impact factor: 4.379

6.  Primary myogenesis in the sand lizard (Lacerta agilis) limb bud.

Authors:  Damian Lewandowski; Magda Dubińska-Magiera; Arnold Garbiec; Małgorzata Daczewska
Journal:  Dev Genes Evol       Date:  2019-06-18       Impact factor: 0.900

Review 7.  Mechanical Regulation of Limb Bud Formation.

Authors:  Yvenn Sermeus; Jef Vangheel; Liesbet Geris; Bart Smeets; Przemko Tylzanowski
Journal:  Cells       Date:  2022-01-26       Impact factor: 6.600

8.  A novel role for syndecan-3 in angiogenesis.

Authors:  Giulia De Rossi; James R Whiteford
Journal:  F1000Res       Date:  2013-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.